T1	Participants 91 132	patients with superficial bladder cancer.
T2	Participants 293 354	superficial bladder cancer following transurethral resection.
T3	Participants 363 399	Sixty-three patients were randomized
T4	Participants 454 513	patients enrolled were elderly people (mean age, 71 years).
T5	Participants 1665 1746	patients with pulmonary tuberculosis or aged patients with primary bladder tumors
